Skip to main content
Clinical Trials/NCT05097456
NCT05097456CompletedNot Applicable

Randomized, Double-blind, Sham-controlled Clinical Trial for Evaluating the Efficacy of Fractional Carbon Dioxide Laser in the Treatment of Stress Urinary Incontinence

Rambam Health Care Campus1 site in 1 country125 target enrollmentStarted: March 1, 2020Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
125
Locations
1
Primary Endpoint
Pad weight test

Study Overview

Brief Summary

The study is intended to assess the safety and efficacy of Carbon dioxide AcuPulse laser treatment in patients with stress urinary incontinence. Eligible subjects will be randomized to either receive 3 laser or 3 sham treatment sessions, 4 weeks apart and 3 follow up visits 3, 6 and 12 months following the last treatment.

Detailed Description

Following a screening visit, eligible subjects will be enrolled into the study. Subjects will be randomized into either laser treatment or sham treatment. Each subject will receive 3 treatments 4 weeks apart and 3 follow up visits, at 3, 6 and 12 months following the last treatment.

Further demographic information and patient history will be obtained from the subjects' electronic files.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Participant, Care Provider)

Eligibility Criteria

Ages
30 Years to 70 Years (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Negative urine analysis.
  • •Normal Pap smear test from the recent 3 years.
  • •No previous gynecological laser treatments.
  • •Able and willing to comply with the treatment/follow-up schedule and requirements.

Exclusion Criteria

  • •Active genital infection.
  • •Subject presenting abnormal Pap result from the last three years.
  • •Recurring urinary tract infection or recurring infection of genital herpes or candida (> 2 episodes in the recent year).
  • •Transvaginal mesh implant.
  • •Serious systemic disease or any chronic condition that could interfere with study compliance.
  • •Any vaginal bleeding of unknown reason.

Arms & Interventions

Laser treatment

Active Comparator

carbon dioxide treatment

Intervention: carbon dioxide laser (Device)

Sham treatment

Sham Comparator

sham treatment

Intervention: sham laser (Device)

Outcomes

Primary Outcomes

Pad weight test

Time Frame: From treatment up to 12 months post treatment

Change in pad weight

Secondary Outcomes

  • Urinary distress index questionnaire(From treatment up to 12 months post treatment)
  • Cough test(From treatment up to 12 months post treatment)
  • International consultation on incontinence questionnaire-urinary incontinence(From treatment up to 12 months post treatment)
  • Pelvic organ prolapse/urinary incontinence sexual questionnaire(From treatment up to 12 months post treatment)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

ROY LAUTERBACH MD

Principal investigator

Rambam Health Care Campus

Study Sites (1)

Loading locations...

Similar Trials